BSE demat auction listing for settlement number 787 covering securities across 154 scrips with quantities to be auctioned on December 31, 2025.
Impact
Medium
Severity
Medium
Justification
Routine demat auction affecting 154 scrips including several large-cap stocks. While operationally important for settlement process, this is a regular market mechanism with localized impact on specific quantities.
BSE demat auction settlement listing 154 securities with quantities to be auctioned across various scrips including major companies like Reliance Industries, Tata Motors, and Adani Enterprises.
Impact
Medium
Severity
Medium
Justification
Routine demat auction settlement affecting 154 securities with varying quantities; primarily impacts brokers and clearing members who failed to deliver securities, requiring auction purchase to fulfill obligations
List of securities and quantities involved in demat auction settlement number 783 dated December 24, 2025.
Impact
Medium
Severity
Medium
Justification
Routine demat auction settlement affecting multiple securities with varying quantities; impacts specific brokers and clients involved in delivery failures
BSE demat auction settlement number 783 listing securities available for auction with quantities across various scrips.
Impact
Low
Severity
Low
Justification
Routine demat auction notice for settlement clearing with specific quantities for affected scrips. Impacts only participants with delivery obligations in listed securities.
BSE demat auction settlement listing 101 scrips with quantities to be auctioned for settlement number 783.
Impact
Medium
Severity
Medium
Justification
Regular demat auction for delivery shortages affecting 101 scrips. Medium impact as it relates to settlement obligations but is a routine market operation.
BSE demat auction settlement for delivery shortages across 130 scrips with quantities ranging from 1 to 50,000 shares.
Impact
Low
Severity
Low
Justification
Routine demat auction for settlement of delivery shortages; standard market operations procedure affecting specific scrips with limited market-wide impact